Diabetes is an insidious cardiometabolic condition that continues to affect a growing population of young Americans, and is associated with high blood pressure, lipid abnormalities, and renal disease. The disease and its clinical sequelae are tightly interwoven with cardiovascular disease (CVD), acute coronary syndrome, and stroke. Consequently, there are substantial clinical implications for the optimal management of any underlying cardiometabolic disorder. While the topic of “metabolic syndrome” remains controversial and inconsistently defined, Dr Michael Weber emphasizes that glycosylated hemoglobin A1c (HbA1c), while the standard measure for the management of diabetes, is only one component of the overall picture - it is also essential to appropriately control body weight and size, blood pressure, and lipid levels.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
RFK Jr Claims HHS Has Not Fired Working Scientists, Canceled Lifesaving Research
May 15th 2025Robert F. Kennedy Jr’s congressional hearing featured numerous statements from the secretary of HHS, including denouncing claims of cutting down the HHS and the National Institutes of Health.
Read More
Trump Administration Walks Back Mental Health Parity in Insurance Coverage
May 13th 2025The Trump administration has decided to further debate the federal rule passed during the Biden administration that guaranteed insurance coverage for treatment of mental illness and substance abuse.
Read More